Bank of America’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
Other funds holding BNR
KCM
CL
NAMA
RWMG
HH
Bank of America's BNR Position: Q1 2026 in Review
Bank of America reduced its Burning Rock Biotech (BNR) stake by 0.05% in Q1 2026, selling an estimated $367 and leaving 29,164 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #4930.
Bank of America first reported a position in BNR in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.09M in Q2 2021. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.
- Bank of America held 29,164 shares of Burning Rock Biotech worth $470K as of Q1 2026.
- Bank of America sold 14 Burning Rock Biotech shares in Q1 2026, an estimated $367.
- Burning Rock Biotech made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4930 holding.
- Bank of America first reported a position in Burning Rock Biotech in Q3 2020 and has held it in 23 quarters since.
- Bank of America's Burning Rock Biotech position peaked at $2.09M in Q2 2021.
- 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.